Corinne Jansen MD
Gynecologic Oncology
Gynecologic Oncology Fellow
Join to View Full Profile
101 Dudley StProvidence, RI 02905
Phone+1 401-274-1122
Fax+1 401-459-0100
Dr. Jansen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Corinne Jansen is an obstetrician-gynecologist specializing in gynecologic oncology, practicing in Providence, RI. She completed her residency in Obstetrics and Gynecology at Beth Israel Deaconess Medical Center, followed by a fellowship in Gynecologic Oncology at Women and Infants Hospital of Rhode Island/Brown University. She graduated from the David Geffen School of Medicine at UCLA in 2018. Dr. Jansen has authored several publications, including research on chemotherapy-induced changes in ovarian cancer, rare case studies involving carcinoma and molar pregnancy, and evaluations of cancer surveillance methods.
Education & Training
Women and Infants Hospital of Rhode Island/Brown UniversityFellowship, Gynecologic Oncology, 2022 - 2025
Beth Israel Deaconess Medical CenterResidency, Obstetrics and Gynecology, 2018 - 2022
David Geffen School of Medicine at UCLAClass of 2018
Certifications & Licensure
CA State Medical License 2025 - 2027
RI State Medical License 2022 - 2026
MA State Medical License 2018 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Publications & Presentations
PubMed
- Knowledge of and Attitudes Towards End-of-Life Doulas Among Gynecologic Oncologists.Gabriela Weigel, Corinne Jansen, Chioma Anaemejeh, Rachel Flink-Bochacki, Katherine Miller
The American Journal of Hospice & Palliative Care. 2025-03-12 - Small molecule inhibition of ubiquitin C-terminal hydrolase L1 alters cell metabolism proteins and exerts anti- or pro-tumorigenic effects contingent upon chemosensiti...Corinne Jansen, Julia McAdams, Chloe Kim, Payton De La Cruz, Angelica Salaverria
Frontiers in Pharmacology. 2025-01-01 - Neoadjuvant chemotherapy induces phenotypic mast cell changes in high grade serous ovarian cancer.Julia McAdams, Jasmine Ebott, Corinne Jansen, Chloe Kim, Daniela Maiz
Journal of Ovarian Research. 2024-09-28
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
